The Effectiveness and Adverse Events of Eribulin Monotherapy in Indonesian Metastatic Breast Cancer (MBC) Patients
This study suggests that eribulin monotherapy is associated with disease control and survival benefits in Indonesian MBC patients while maintaining a manageable safety profile. However, further prospective studies are needed to confirm its long-term efficacy, impact beyond 6 cycles, and comparative effectiveness relative to other chemotherapy regimens.
Authors
- Kristina Maria Siswiandari
- Walta Gautama
- Dedy Hermansyah (ORCID: https://orcid.org/0000-0002-5980-2556)
- Putu Anda Tusta Adiputra (ORCID: https://orcid.org/0000-0003-2676-8037)
- Nur Qodir (ORCID: https://orcid.org/0000-0003-2124-2079)
- Dhian Hangesti
Institutions
- Universitas Sumatera Utara (ID)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-05-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.5.1773
- Citations
- 1
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.05